Panacea Life Sciences Holdings, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $0.00.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $75.00K.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, new issues for fiscal 2023 was $75.00K.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, new issues for fiscal 2020 was $385.00K, a 94.66% decline from fiscal 2019.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, new issues for fiscal 2019 was $7.22M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $75.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | |
| 2023-06-30 | $75.00K 10-Q · filed 2023-08-15 | |
| 2023-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2024-04-01 | |
| 2020-12-31 | $385.00K 10-K/A · filed 2021-04-23 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-18 | |
| 2020-06-30 | $250.00K 10-Q · filed 2020-11-18 | |
| 2020-03-31 | $100.00K 10-Q/A · filed 2021-05-27 | |
| 2019-12-31 | $7.22M 10-K/A · filed 2021-04-23 | |
| 2019-09-30 | $1.53M 10-Q · filed 2020-11-18 | |
| 2019-06-30 | $2.17M 10-Q · filed 2020-11-18 | |
| 2019-03-31 | $3.31M 10-Q · filed 2020-11-18 |